The Peter Attia Drive

Podbit · The Peter Attia Drive

#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.

Explore episode Jun 8, 2026
Health & Fitness
Ezetimibe's Surprising Brain Effect

#395 - Brain lipidology: understanding APOE, cholesterol ho… · Jun 8, 2026 Health & Fitness

Ezetimibe works in the gut and can't cross the blood-brain barrier — but its metabolite, ezetimibe glucuronide, can. Animal studies show it interferes with hexokinase and reduces brain protein glycosylation, producing anti-inflammatory effects. Neurologists already report anecdotal cognitive benefits in patients.

Where this was said

Ezetimibe and potential cognitive benefits

At 1:19:40 · chapter starts 1:19:30

Peter asks about ezetimibe — a drug that works in the gut by blocking intestinal cholesterol absorption and might seem irrelevant to brain health. Tom acknowledges it shouldn't have a brain effect based on first principles, but then reveals that ezetimibe's main metabolite, ezetimibe glucuronide, can cross the blood-brain barrier in small amounts. In animal studies, it interferes with hexokinase and reduces glycosylation of brain proteins, producing anti-inflammatory effects. Neurologists who specialize in Alzheimer's prevention — Tom names Richard Isaacson and Kelly Endiotes — have anecdotally observed cognitive benefits in patients taking ezetimibe, beyond what would be expected from ApoB lowering alone. Tom frames a plausible clinical strategy: for APOE4 carriers with elevated ApoB, a combination of low-dose statin plus ezetimibe may target both cardiovascular and brain health simultaneously. He notes that existing trial biobanks from ezetimibe studies could in principle be mined for pre- and post-treatment P-tau and amyloid-beta-40/42 data without needing a new trial.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.